[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_4985 

# __Use of graphene oxide go as an effective virucide__

## Articles mentionning the risk

* [Ayub_graphene-based_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_404.md)

## Mitigations of this risk

* [Research into alternative antimicrobial compounds, rotation of antimicrobial agents](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_6858.md)

## Name of the risk

Potential resistance to GO and reduced effectiveness over time

## People affected by this risk

* [Medical professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Public health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_0.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_425.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Antimicrobial resistance research](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6045.md)
* [Development of alternative virucides](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6046.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Healthcare and medical risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_15.md)

